Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
News Release
Risk & Insurance: Treating Pain Without Drugs
From high praise to a spiraling crash, opioid-based pain medications are out of favor.
Mitchell
News Release
Arizona Senate Committee Gives Qualified Approval to SB 1111
The Arizona Senate Commerce and Public Safety Committee voted this week to recommend SB1111 on a 6-2 vote.
Workers' Comp
News Release
Stone Point Capital to Acquire Genex Services from Funds Advised by Apax Partners
Wayne, PA – Feb.
Mitchell
Article
Motor Vehicle Markets Q4 2017
We recap the motor vehicle markets trends from Q4 2017, highlighting the best-selling U.S.
WorkCompWire
Article
WorkCompWire: Jim Harris: Unleashing Powerful Insights Hidden in Your Bill Review Data
In this column, we look at five strategies that sophisticated vendors are deploying to elevate the bill review process to a strategic, data-f
Workers' Comp
Blog
A Look Back at 40 Years
Whether good or bad, most people see turning age 40 as a major milestone.